Crossmark

Clinical significance of T cell metabolic reprogramming in cancer

Crossref DOI link: https://doi.org/10.1186/s40169-016-0110-9

Published Online: 2016-08-10

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Herbel, Christoph

Patsoukis, Nikolaos

Bardhan, Kankana

Seth, Pankaj

Weaver, Jessica D.

Boussiotis, Vassiliki A. https://orcid.org/0000-0002-3963-1518
Funding

Funding for this research was provided by:

National Institutes of Health (CA183605)

National Institutes of Health (CA183605S1)

National Institutes of Health (AI098129‐01)

U.S. Department of Defense (PC140571)

National Cancer Institute (CA183605)

National Cancer Institute (CA183605S1)

Foundation for the National Institutes of Health (AI098129-01)

U.S. Department of Defense (PC140571)

U.S. Department of Defense (PC140571)
License Information

Version of Record valid from 2016-08-10

Text and Data Mining valid from 2016-08-10

Version of Record valid from 2016-08-10
More Information

Article History

Received: 12 April 2016

Accepted: 15 July 2016

First Online: 10 August 2016